Microbiome-derived ethanol in nonalcoholic fatty liver disease

[1]  N. Lanthier,et al.  A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. , 2021, The New England journal of medicine.

[2]  F. Bäckhed,et al.  Gut microbial metabolites as multi-kingdom intermediates , 2020, Nature reviews. Microbiology.

[3]  Yoon-Ho Choi,et al.  Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study , 2020, Journal of gastroenterology and hepatology.

[4]  V. Tremaroli,et al.  A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study , 2020, Journal of internal medicine.

[5]  V. Tremaroli,et al.  Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects , 2020, Journal of internal medicine.

[6]  David F Wilson,et al.  Ethanol metabolism: The good, the bad, and the ugly. , 2020, Medical hypotheses.

[7]  R. Carr,et al.  Alcohol effects on hepatic lipid metabolism , 2020, Journal of Lipid Research.

[8]  P. Bedossa,et al.  Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. , 2019, Journal of hepatology.

[9]  Ruifu Yang,et al.  Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. , 2019, Cell metabolism.

[10]  S. Rampelli,et al.  HumanMycobiomeScan: a new bioinformatics tool for the characterization of the fungal fraction in metagenomic samples , 2019, BMC Genomics.

[11]  F. Tacke,et al.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.

[12]  Evgeni Levin,et al.  Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography , 2018, Nature Medicine.

[13]  Rob Knight,et al.  Regional variation limits applications of healthy gut microbiome reference ranges and disease models , 2018, Nature Medicine.

[14]  R. Bataller,et al.  Alcoholic liver disease , 2018, Nature Reviews Disease Primers.

[15]  H. Cortez‐Pinto,et al.  EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. , 2018, Journal of hepatology.

[16]  Jens Nielsen,et al.  An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. , 2018, Cell metabolism.

[17]  J. Fell,et al.  Estimation of the Potential Effectiveness of Lowering the Blood Alcohol Concentration (BAC) Limit for Driving from 0.08 to 0.05 Grams per Deciliter in the United States , 2017, Alcoholism, clinical and experimental research.

[18]  A. Diehl,et al.  Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis , 2017, The New England journal of medicine.

[19]  Luis Pedro Coelho,et al.  Towards standards for human fecal sample processing in metagenomic studies , 2017, Nature Biotechnology.

[20]  P. Paci,et al.  Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach , 2017, Hepatology.

[21]  Robert C. Edgar,et al.  UNOISE2: improved error-correction for Illumina 16S and ITS amplicon sequencing , 2016, bioRxiv.

[22]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[23]  W. Bockelmann,et al.  Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions , 2016, Front. Microbiol..

[24]  Josivan G. Lima,et al.  Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis. , 2015 .

[25]  J. Schattenberg,et al.  Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease , 2015, Gut.

[26]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[27]  S. Horgan,et al.  Benefits of bariatric surgery do not reach obese men. , 2014, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[28]  P. Bedossa.  Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease , 2014, Hepatology.

[29]  Intawat Nookaew,et al.  Metagenomic Data Utilization and Analysis (MEDUSA) and Construction of a Global Gut Microbial Gene Catalogue , 2014, PLoS Comput. Biol..

[30]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[31]  Eduard Szöcs,et al.  taxize: taxonomic search and retrieval in R , 2013, F1000Research.

[32]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[33]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[34]  M. Mitrović,et al.  Endogenous ethanol production in patients with diabetes mellitus as a medicolegal problem. , 2012, Forensic science international.

[35]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[36]  Robert C. Edgar,et al.  Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..

[37]  Vanessa S Teaberry,et al.  Similarities and Differences in the Pathogenesis of Alcoholic and Nonalcoholic Steatohepatitis , 2009, Seminars in liver disease.

[38]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[39]  Diego Matteuzzi,et al.  Kinetics and Metabolism of Bifidobacterium adolescentis MB 239 Growing on Glucose, Galactose, Lactose, and Galactooligosaccharides , 2007, Applied and Environmental Microbiology.

[40]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[41]  T. Risby,et al.  Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. , 2000, Gastroenterology.

[42]  A. Siitonen,et al.  Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine. , 1996, Alcohol and alcoholism.

[43]  R. McCallum,et al.  Growth yields and fermentation balance of Bacteroides fragilis cultured in glucose-enriched medium , 1979, Journal of bacteriology.

[44]  J. Zeikus,et al.  Fermentation of cellulose and cellobiose by Clostridium thermocellum in the absence of Methanobacterium thermoautotrophicum , 1977, Applied and environmental microbiology.

[45]  A. Cederbaum.  Alcohol metabolism. , 2012, Clinics in liver disease.

[46]  G. Farrell,et al.  LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis , 2006 .

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[48]  J. Zeikus,et al.  Fermentation of cellulose and cellobiose by 'Clostridium thermocellum' in the absence and presence of 'Methanobacterium thermoautotrophicum'. (Thermophilic cellulose fermentation) , 1975 .